Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial. [electronic resource] by
- Deodhar, Atul
- Helliwell, Philip S
- Boehncke, Wolf-Henning
- Kollmeier, Alexa P
- Hsia, Elizabeth C
- Subramanian, Ramanand A
- Xu, Xie L
- Sheng, Shihong
- Agarwal, Prasheen
- Zhou, Bei
- Zhuang, Yanli
- Ritchlin, Christopher T
Producer: 20200409
In:
Lancet (London, England) vol. 395
Availability: No items available.
|